Cas 851014-19-2,2-(4-Benzyl-2-isopropyl-piperazin-1-yl)-4-(2,4-difluoro-phenyl)-quinazoline

851014-19-2

Post Buying Request

Basic information

Product Name: 2-(4-Benzyl-2-isopropyl-piperazin-1-yl)-4-(2,4-difluoro-phenyl)-quinazoline
Synonyms: 2-(4-Benzyl-2-isopropyl-piperazin-1-yl)-4-(2,4-difluoro-phenyl)-quinazoline
CAS NO:851014-19-2
Molecular Formula:
Molecular Weight: 458.554
EINECS: N/A
Product Categories: N/A
Mol File: 851014-19-2.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-(4-Benzyl-2-isopropyl-piperazin-1-yl)-4-(2,4-difluoro-phenyl)-quinazoline(CAS DataBase Reference)
NIST Chemistry Reference: 2-(4-Benzyl-2-isopropyl-piperazin-1-yl)-4-(2,4-difluoro-phenyl)-quinazoline(851014-19-2)
EPA Substance Registry System: 2-(4-Benzyl-2-isopropyl-piperazin-1-yl)-4-(2,4-difluoro-phenyl)-quinazoline(851014-19-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 851014-19-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

851014-19-2 Suppliers

Recommended suppliersmore

851014-19-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 851014-19-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,0,1 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 851014-19:
(8*8)+(7*5)+(6*1)+(5*0)+(4*1)+(3*4)+(2*1)+(1*9)=132
132 % 10 = 2
So 851014-19-2 is a valid CAS Registry Number.

851014-19-2Upstream product

851014-19-2Downstream Products

851014-19-2Relevant articles and documents

Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders

-

Page/Page column 34, (2010/02/11)

This invention relates to compounds of the formula 1 wherein R1, R2, and R3 and R4 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 851014-19-2